Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study. Radiol Oncol [Internet]. 2020 May 31 [cited 2026 Oct. 23];54(2):233-6. Available from: https://www.radioloncol.com/index.php/ro/article/view/3362